Position in VRTX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$55,682,439
+$17,060,302 QoQ
Shares Held
112,098
+29.6% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#161
of 1,732 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 13%
Shared 10%
None 77%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $250,401,460 across 107 Biotechnology names. VRTX ranks #1 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
112,098 | $55,682,439 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
196,791 | $15,603,558 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
187,447 | $14,671,476 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
32,580 | $12,109,008 | |
| 5 | TECH |
BIO-TECHNE Corp
|
122,377 | $8,645,935 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,758 | $8,578,663 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,797 | $7,163,610 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
186,110 | $6,925,153 |
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,682,439 | 112,098 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $38,622,137 | 86,492 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $46,501,135 | 102,570 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $39,841,926 | 101,731 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $45,773,681 | 102,816 | Shares | Defined | 2025-09-26 | |
| 2025-03-31 | $51,657,570 | 106,550 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $45,563,893 | 113,146 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $60,118,566 | 129,265 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $72,567,229 | 154,820 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $63,762,825 | 152,539 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $62,037,703 | 152,468 | Shares | Other | 2024-02-09 | |
| 2023-09-30 | $55,723,247 | 160,244 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $60,635,148 | 172,303 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $55,346,771 | 175,665 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $41,967,241 | 145,326 | Shares | Other | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||